Albemarle Corporation

Equities

ALB

US0126531013

Specialty Chemicals

Market Closed - Nyse 04:00:01 2023-12-01 pm EST Intraday chart for Albemarle Corporation 5-day change 1st Jan Change
126.16 USD +4.03% -2.10% -41.82%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Will Powell deliver an early Christmas present?
ANALYST RECOMMENDATIONS : Abbvie, Boeing, IBM, Lululemon Athletica, Meta Platforms...
Australia's $2.5 trln pension funds set to flex muscles in corporate dealmaking RE
Chile mining body says new lithium projects needed beyond SQM, Albemarle RE
Top Midday Decliners MT
US Equity Indexes Mixed as Stronger Black Friday Sales 'Defy Expectations of Material Slowdown' MT
US Equity Indexes Mixed in Midday Trading MT
Berenberg Bank Adjusts Albemarle Price Target to $135 From $235, Maintains Hold Rating MT
ANALYST RECOMMENDATIONS : Burberry, Albemarle, Linde...
NZ's EBOS not to proceed with $2.44 billion Greencross acquisition RE
Argentina Lithium & Energy Corp. Up 16% After Announcing Accelerated Exploration Plan MT
Albemarle Promotes Cynthia Lima to Chief External Affairs and Communications Officer MT
Albemarle Corporation Announces the Promotion of Cynthia Lima as Senior Vice President, Chief External Affairs and Communications Officer CI
As Aussie magnates gatecrash lithium deals, bankers get creative RE
The ideal scenario is becoming reality
ANALYST RECOMMENDATIONS : Amazon, Best Buy, Diageo, The Mosaic Co, Unilever...
Livent starts Australian campaign for $10.6 billion Arcadium Lithium merger RE
Livent starts Australian campaign for $10.6 bln Arcadium Lithium merger RE
BMO Capital Adjusts Albemarle's Price Target to $180 From $265, Keeps Outperform Rating MT
All good things must come to an end
ANALYST RECOMMENDATIONS : Best Buy, Diageo, Eli Lilly, Estee Lauder, Home Depot...
Albemarle Facing Downside Risk Linked to Lithium Prices, Morgan Stanley Says MT
UBS Downgrades Albemarle to Neutral From Buy, Cuts Price Target to $140 From $253 MT
Deutsche Bank Adjusts Albemarle Price Target to $155 From $165, Maintains Buy Rating MT
RBC Cuts Price Target on Albemarle to $163 From $212 on Lower Lithium Pricing, Destocking, Keeps Outperform Rating MT
Chart Albemarle Corporation
More charts
Albemarle Corporation is one of the world's leading manufacturers of specialty chemicals. The group's products are aimed primarily at the petroleum refining, energy storage, consumer electronics, construction, crop protection, automotive, food safety and pharmaceuticals industries. Net sales break down by family of products as follows: - lithium and polymer solutions (68.4%); - bromine (19.3%); - catalysts (12.3%). Exports account for 87.9% of net sales.
Calendar
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.16USD
Average target price
191.73USD
Spread / Average Target
+51.97%
Consensus
1st Jan change Capi.
-41.82% 14 231 M $
+32.18% 54 670 M $
+6.81% 43 632 M $
+16.59% 34 621 M $
-0.72% 16 642 M $
+2.75% 15 732 M $
+38.37% 10 139 M $
-3.07% 8 716 M $
-39.99% 8 227 M $
-32.16% 7 859 M $
Other Specialty Chemicals
  1. Stock
  2. Equities
  3. Stock Albemarle Corporation - Nyse
  4. News Albemarle Corporation
  5. Berenberg Bank Adjusts Albemarle Price Target to $235 From $220, Maintains Hold Rating
The best tools reserved for subscribers to boost the performance of your investments!
Optimize my profits
fermer